The FDA recently announced that the popular heartburn medicine Zantac contains low levels of a chemical referred to as NDMA. NDMA is classified as a probable human carcinogen by the EPA, meaning that it could cause cancer. To be clear, NDMA was found in other heartburn drugs that contain ranitidine, not just Zantac. While Zantac’s manufacturer has not halted sales in the US, it has stopped shipping the drug and has issued a recall in India and Hong Kong. While the FDA has not issued a recall, this issue comes on the heels of its recall for the popular blood pressure drug, valsartan.
When pharmaceutical companies sell dangerous drugs, the product liability attorneys at Slappey & Sadd believe that people injured by those drugs are entitled to compensation. With decades of experience, we have the knowledge and legal skills you need to fight for your rights and hold those companies accountable. If you’re suffering from an illness due to dangerous drugs, call us at 888-474-9616 or reach out online to schedule a free consultation and case evaluation.